Stablecoin Development Corp. (SDEV)
Stablecoin Development Corp. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Emeryville, CA, US. The stock last traded at $1.02, down 1.92% on the session, giving a market capitalisation of $51.5M. On trailing twelve-month figures it carries a trailing P/E of 0.07, a net margin of 10354.3%. Its beta of 0.09 implies it has historically moved less than the broad market.
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.